Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

James B. Hickey, Jr. Joins IMRIS Board of Directors

IMRSQ
James B. Hickey, Jr. Joins IMRIS Board of Directors

WINNIPEG, MB, May 30, 2013 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced the appointment of James Hickey to the company's board of directors effective June 1, 2013.

Mr. Hickey is an experienced medical device industry executive who brings more than 25 years of experience in building, managing and leading successful medical technology companies.  He began his career with American Hospital Supply/Baxter Healthcare in 1977.  Subsequently he has served as the CEO of two publicly traded and two private medical device companies and is currently President and CEO of Phraxis, a medical device developer of vascular access products for the dialysis market. From 1998 until 2011, Mr. Hickey served on the board of Vital Images, including having served as the Chair of the Board.

"The addition of Jim to our board brings extensive industry knowledge and leadership experience that will benefit our company, our customers and our shareholders," said David Graves, Chairman of the Board of Directors.  "Jim's contribution to the strategic thinking in combination with his broad industry experience will make a meaningful difference to IMRIS."

Mr. Hickey has served on numerous medical device boards and was honored by Twin Cities Business Monthly as one of their "Corporate Directors of the Year" in 2005.

"I am delighted to join the IMRIS' board of directors," said Mr. Hickey.  "IMRIS' VISIUS® Surgical Theatre is the leading technology in the market, and with the development of the SYMBIS™ Surgical Robotic System, has the potential to improve outcomes for patients while reducing the cost of care.  I look forward to contributing to the growth of the company."

Mr. Hickey will replace Mr. Robert Courteau who has resigned from the board of directors effective May 31, 2013.

About IMRIS

IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre - a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. VISIUS Surgical Theatres serve the neurosurgical, cardiovascular and cerebrovascular markets and have been selected by leading medical institutions around the world.

 

SOURCE IMRIS Inc.



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today